AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Foreign Filer Report Aug 27, 2019

7004_rns_2019-08-26_3d6e21b7-c09b-45a8-8e4a-d80e63f9771f.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

_________ false

����� ����� ��"� 2 379
KITOV PHARMA LTD
Corporation no: 520031238 10994
- - -
Israel Securities Authority Tel Aviv Stock Exchange C001 ( Public ) Reported via MAGNA: 26/08/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-088774 Time of broadcast: 23:34 23:17:24

Complementary report for a report sent on date 09/08/2019 whose reference number was 2019-02-083044

Main details added/ completed: XBRL files submitted to the SEC

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2019 Commission File Number: 001-37643 KITOV PHARMA LTD. Amendment to previously furnished Form 6-K in order to submit the condensed consolidated unaudited interim financial statements as of June 30, 2019, and for the six months then ended in XBRL format. The XBRL files are on the SEC's website�

f6k081319a1_kitovpharmaltdEDGAR2_Bannerless_isa.pdf

Link of EDGAR Filing: https://www.sec.gov/Archives/edgar/data/1614744/000121390019016695/0001213900-19-016695-index.htm

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2019-02-082807     2019-02-083044
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 06/08/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel

Talk to a Data Expert

Have a question? We'll get back to you promptly.